Cargando…
Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
The detection of serum biomarkers can aid in the diagnosis of lung cancer. In recent years, an increasing number of lung cancer markers have been identified, and these markers have been reported to have varying diagnostic values. A method to compare the diagnostic value of different combinations of...
Autores principales: | Yang, Qixian, Zhang, Ping, Wu, Rongqiang, Lu, Kefeng, Zhou, Hongxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188592/ https://www.ncbi.nlm.nih.gov/pubmed/30364165 http://dx.doi.org/10.1155/2018/2082840 |
Ejemplares similares
-
Impact of HSP90α, CEA, NSE, SCC, and CYFRA21-1 on Lung Cancer Patients
por: Zhou, Wenwen, et al.
Publicado: (2021) -
Prognostic Value of Tumor Markers, NSE, CA125 and SCC, in Operable NSCLC Patients
por: Yu, Dangfan, et al.
Publicado: (2013) -
Retracted: Impact of HSP90α, CEA, NSE, SCC, and CYFRA21-1 on Lung Cancer Patients
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Methylated PTGER4 is better than CA125, CEA, Cyfra211 and NSE as a therapeutic response assessment marker in stage IV lung cancer
por: Zhang, Yunxia, et al.
Publicado: (2020) -
Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis)
por: Bagaria, Bhawna, et al.
Publicado: (2013)